Acquisition of Isoniazid 300 mg/5ml Injection Solution Fr 5 ml IV AUE DG 1629
About This Opportunity
TranslatedThis tender pertains to the acquisition of Isoniazid 300 mg/5ml injection solution, packaged in 5 ml vials for intravenous use. Isoniazid is a critical medication used primarily in the treatment of tuberculosis. The procurement is essential for ensuring the availability of this vital drug in healthcare facilities. The tender outlines the need for suppliers to provide high-quality pharmaceutical products that meet stringent safety and efficacy standards. Key requirements for bidders may include the provision of relevant certifications, adherence to regulatory guidelines, and the ability to deliver the product within specified timelines. Additionally, suppliers should demonstrate experience in handling pharmaceutical contracts and maintaining compliance with health regulations. The location of the delivery and the specific sector involved in this procurement are not explicitly mentioned, but it is implied that the products will be utilized within a healthcare context. Interested parties are encouraged to review the tender documents thoroughly to understand the full scope of the requirements and the submission process. This acquisition is part of a broader effort to enhance public health initiatives and ensure that essential medications are readily available to those in need.
This is a supplies contract in the health and medical services, information and communication technology and trade and industry sectors, with a focus on Pharmaceuticals, Infectious Diseases, artificial intelligence and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 555.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição de Isoniazida 300 mg/5ml Sol Inj Fr 5 ml IV AUE DG 1629" pertains to the procurement of Isoniazid, a critical pharmaceutical product used in the treatment of tuberculosis. This tender is being issued in Portugal and is part of the public contracts managed through the Portal BASE, which centralizes information on public procurement across mainland Portugal and its autonomous regions.
Contracting authorities typically seek qualified suppliers capable of providing high-quality pharmaceutical products that meet stringent regulatory standards. For this specific tender, bidders are expected to supply Isoniazida in a concentration of 300 mg per 5 ml in a ready-to-use injectable format. The specified packaging is 5 ml vials, which is standard for intravenous administration, ensuring ease of use in clinical settings.
Prospective suppliers must demonstrate compliance with pharmaceutical regulations, including certifications of Good Manufacturing Practices (GMP) and relevant quality assurance protocols. Additionally, bidders may need to provide evidence of successful past performance in similar contracts, including product efficacy and safety data.
Vendors should also be prepared to meet delivery timelines and logistical requirements to ensure that the product is available when needed, thereby supporting public health initiatives aimed at combating tuberculosis in the region. The procurement process emphasizes transparency and competitive bidding, inviting reputable suppliers to participate in enhancing healthcare outcomes in Portugal.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 10, 2026. Last refreshed 9 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Alto Minho, EPE (ULSAM)
Unidade Local de Saúde do Alto Minho, EPE (ULSAM) has issued 512 procurement notices on BidsFactory, including 0 currently open and 462 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €555. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Inovemed - Produtos Farmacêuticos, Lda. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Alto Minho, EPE (ULSAM) in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.